-
P2Y11 Antagonist NF 340 in Cell Invasion Studies
2026-09-24
Use NF 340 to test whether P2Y11 signaling contributes to QPRT-associated breast cancer cell migration, invasion, and myosin light-chain phosphorylation. This workflow pairs receptor pharmacology with pathway readouts and orthogonal controls, while keeping suggested assay settings distinct from conditions reported in the literature.
-
QPRT Promotes Breast Cancer Invasion Through MLC
2026-09-23
Liu et al. link elevated quinolinate phosphoribosyltransferase (QPRT) with breast cancer cell migration and invasion, and identify myosin light-chain phosphorylation as a downstream correlate. Their inhibitor experiments implicate P2Y11-associated purinergic signaling and related contractility pathways, while leaving the precise molecular connection and its in vivo relevance to be tested.
-
Human PSC Myogenic Progenitors: Long-Term Engraftment
2026-09-23
Khosrowpour et al. show that a purified CD82+ ERBB3+ NGFR+ population from human PSC-derived teratomas can produce durable human dystrophin-positive muscle and establish a dynamic PAX7-positive satellite cell pool in NSG-mdx4Cv mice. The study’s longitudinal design, maturation analysis, and cryopreservation experiment strengthen the case for teratoma-derived progenitors as a research and translational platform for skeletal muscle regeneration.
-
CTP Solution (100 mM): From IVT to Assay Confidence
2026-09-22
CTP Solution (100 mM) is more than an in vitro transcription input: it is an upstream quality variable in mRNA research. This article connects nucleotide control with the assay decisions required to interpret localized p21 mRNA–LNP studies in bladder cancer.
-
MK-0812 Workflow for CCR2-Driven MASH Research
2026-09-22
MK-0812 provides a selective way to test whether CCR2-dependent monocyte trafficking is a downstream driver of gut–liver inflammation rather than a primary intestinal defect. This workflow pairs MCP-1 challenge assays, blood and tissue flow cytometry, and TM6SF2-deficiency models to separate immune recruitment from barrier, microbiota, and lipid-signaling effects.
-
Ashwagandha Digestion Revealed by LC–MS/MS
2026-09-21
A 2026 study combined simulated gastrointestinal digestion, targeted LC–MS/MS, untargeted metabolomics, and molecular networking to examine how Withania somnifera leaf and root extracts change before absorption. Withaferin A and withanoside IV were transformation-prone, whereas withanolide A was comparatively stable, demonstrating why digestive stability should be evaluated alongside liver metabolism and plasma binding.
-
Gut-Brain Cholinergic Signaling in Seizure Control
2026-09-21
Jia et al. identify a mechanistic gut-brain pathway through which Bacteroides fragilis suppresses seizures, linking colonic ChAT-positive cells, vagal transmission, and downstream brain activity. Their combination of mouse models, circuit-level experiments, microbiota analysis, and a pediatric clinical trial provides a translational framework for microbiota-targeted treatment of refractory epilepsy.
-
Cyclosporin A: From Mechanism to Translation
2026-09-20
Cyclosporin A is more than a conventional calcineurin inhibitor: it is a context-dependent probe of cyclophilin, NFAT, MAPK, and mitochondrial biology. This thought-leadership guide connects its mechanistic architecture with causal experimental design, translational controls, and the limits of extending immunology insights into neuroscience.
-
Bufalin–CRISPR Nanomedicine for Colorectal Cancer
2026-09-19
Liu and colleagues developed a calcium lactate nanoparticle that co-delivers bufalin and CRISPR/Cas9 ribonucleoproteins targeting CD47, linking tumor-cell death with macrophage reprogramming and immune checkpoint disruption. The study reports coordinated pyroptosis, apoptosis, M1-like macrophage polarization, enhanced phagocytosis, and systemic antitumor activity, while also highlighting the translational challenges of combining nanomedicine with genome editing.
-
S63845 MCL1 Inhibitor: Workflow & Applications
2026-09-18
S63845 is a high-affinity MCL1 inhibitor for dissecting mitochondrial apoptosis in hematological and selected solid-tumor models. This practical guide connects dose-response design, BAX/BAK-dependent apoptosis readouts, and combination workflows inspired by recent pancreatic cancer research.
-
P2Y11 Antagonist NF 340 in Invasion Assays
2026-09-18
NF 340 provides a practical way to test whether P2Y11-linked GPCR signaling contributes to breast cancer cell migration, invasion, and myosin light-chain phosphorylation. This guide translates the QPRT–P2Y11 findings into controlled workflows, dose-finding strategies, and troubleshooting steps while separating established evidence from optimization recommendations.
-
WDR36, Glycolysis, and Human Trophectoderm Fate
2026-09-17
The reference study identifies WDR36 as a regulator of human blastoid formation and trophectoderm commitment, linking this developmental function to glucose metabolism and interaction with LDHA. Its combined use of mouse embryos, human pluripotent stem cell-derived blastoids, transcriptomics, and targeted metabolomics provides a mechanistic framework for studying early developmental arrest.
-
ISG20 and CLEC5A in Atherosclerosis: Causal Evidence
2026-09-17
Zhang and colleagues integrated GEO expression data, eQTL evidence, Mendelian randomization, and experimental validation to examine whether immune-associated genes causally influence atherosclerosis. The study highlights ISG20 as a candidate regulator of macrophage lipid accumulation and plaque inflammation while illustrating how genetic inference can prioritize targets for mechanistic follow-up.
-
Pertussis toxin for reproducible immune assays
2026-09-16
This scenario-driven guide explains how Pertussis toxin, SKU B7273, can be incorporated into cell viability, proliferation, and immune-modulation workflows without confusing pathway effects with nonspecific cytotoxicity. It covers assay design, protocol handling, interpretation, and practical vendor-selection criteria for biomedical laboratories.
-
H2S Deficiency and ER Stress in Diabetic Cardiomyopathy
2026-09-16
Guo et al. connected reduced endogenous hydrogen sulfide production with palmitate-associated lipotoxicity, endoplasmic reticulum stress, and myocardial injury in diabetic cardiomyopathy. By combining patient samples, a streptozotocin-induced rat model, and AC16 cardiomyocytes, the study showed that H2S donation and ER-stress inhibition reduced lipid accumulation and apoptosis, while also defining important limits for translating bulk H2S measurements into dynamic cellular imaging.